Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. DeSantis, L
   Preclinical overview of brinzolamide
   SURVEY OF OPHTHALMOLOGY
   
   L. DeSantis, "Preclinical overview of brinzolamide", SURV OPHTHA, 44, 2000, pp. S119-S129
2. D'Andrea, A; D'Andrea, D; Ferreri, G
   Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma
   ACTA OPHTHALMOLOGICA SCANDINAVICA
   
   A. D'Andrea et al., "Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma", ACT OPHTH S, 76, 1998, pp. 36-38
3. SCHMIDT KG; DICK B; VONRUCKMANN A; PILLUNAT LE
   OCULAR PULSE AMPLITUDE AND DORZOLAMIDE
   Der Ophthalmologe
   
   K.G. Schmidt et al., "OCULAR PULSE AMPLITUDE AND DORZOLAMIDE", Der Ophthalmologe, 94(9), 1997, pp. 659-664
4. SIMPSON AJ; GRAY TB; BALLANTYNE C
   A CONTROLLED CLINICAL-TRIAL OF DORZOLAMIDE - A SINGLE-CENTER SUBSET OF A MULTICENTER STUDY
   Australian and New Zealand journal of ophthalmology
   
   A.J. Simpson et al., "A CONTROLLED CLINICAL-TRIAL OF DORZOLAMIDE - A SINGLE-CENTER SUBSET OF A MULTICENTER STUDY", Australian and New Zealand journal of ophthalmology, 24(1), 1996, pp. 39-42